Form 4: Senti Biosciences CEO Timothy Lu Sells Shares to Cover Tax Obligations

Senti Biosciences CEO Timothy Lu sold shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units.

Summary

• Timothy Lu, CEO of Senti Biosciences, sold 3,922 shares of common stock on February 4, 2025, at a price of $4.07 per share.
• He then sold 545 shares on February 6, 2025, at $4.36 per share.
• These sales were executed to cover tax withholding obligations related to the vesting of restricted stock units, according to the company's 'sell-to-cover' policy.
• Following these transactions, Lu directly owns 82,082 shares of Senti Biosciences common stock.
• Lu also indirectly owns 52,839 shares through the Luminen Trust.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the stock sales are related to tax obligations and don't necessarily reflect a change in the CEO's confidence in the company.

Industry Context

Insider sales are a common occurrence, particularly when related to tax obligations from vesting equity. It's important to consider the context of these sales, as they don't always indicate a negative outlook on the company's future.

Key Dates

Keywords

Senti Biosciences, Timothy Lu, stock sale, Form 4, insider trading, tax withholding, restricted stock units, SNTI